EMA shares lessons learned from biosimilars pilot
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropePreclinical studyQuality Assurance and ControlRegulatory Intelligence/Policy